Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human endostatin plus NP vs NP in stage IV NSCLC
CTR20131255Phase 3Active
- Sponsor
- Jiangsu Wuzhong Pharmaceutical Development
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Jiangsu Wuzhong Pharmaceutical Development. Started Mar 2014; status: active.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20131255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131255.